Results 181 to 190 of about 539,663 (302)

Finite element modeling in obstetrics and gynecology: advances, applications, and challenges. [PDF]

Front Med (Lausanne)
Moseley T, Hicks AJ, Cosgriff-Hernandez EM, Rausch MK, Hakim J.   +4 more
europepmc   +1 more source

Dedicated to Gynecology and Obstetrics

Acta Médica del Centro, 2011
José Antonio Gonzáles Acosta, Georgina Díaz Serrano   +1 more
doaj  

Secondary Traumatic Stress in Obstetrics and Gynecology Faculty, House Officers, and Certified Nurse Midwives. [PDF]

Womens Health Rep (New Rochelle)
Campbell E, Morgan HK, Fitzgerald JT, Liang A.   +3 more
europepmc   +1 more source

Cell-free fetal DNA: the new tool in fetal medicine. [PDF]

, 2014
Chitty, LS, Everett, TR
core   +1 more source

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma

International Journal of Cancer, EarlyView.
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja, Peter Micallef, Maria Lycke, Tobias Österlund, Manuel Luna Santamaría, Julia Hedlund Lindberg, Therese Carlsson, Ulf Gyllensten, Anders Ståhlberg, Benjamin Ulfenborg, Anna Linder, Karin Sundfeldt   +11 more
wiley   +1 more source

Factors Influencing Obstetrics and Gynecology Residents' Intentions to Provide Abortion Care after Training. [PDF]

Hawaii J Health Soc Welf
Firouzbakht S, Wong Z, Ronquillo T, Tschann M, Choi SY, Soon R.   +5 more
europepmc   +1 more source

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Contemporary Dissemination Rates Among Research Presented at Obstetrics and Gynecology Subspecialty Conferences. [PDF]

O G Open
Sarker MR, Pasha M, Thompson B, King M, Hutson D, Wiley R, Kunwar N, Canfield D, Adkins S, Rothschild H, Ramos GA, Gyamfi-Bannerman C.   +11 more
europepmc   +1 more source

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source

Internally Filled Fellowship Positions in Obstetrics and Gynecology Before and After 2020. [PDF]

O G Open
McLaughlin HD, Janke MJ, Uppal S, Roberts C, Aaron B, Spencer RJ, Siedel JH, Hong CX.   +7 more
europepmc   +1 more source